News + Filings Holdings
|
JENNISON ASSOCIATES LLC
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 1,839,267 | 767,032 | 46,551,849,000 | 46,522,899,000 | $25,310.00 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 1,072,235 | -683,468 | 28,950,000 | 4,686,000 | $27.00 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 1,755,703 | -685,583 | 24,264,000 | -23,341,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 2,441,286 | 237,722 | 47,605,000 | 11,643,000 | $19.50 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 2,203,564 | 118,038 | 35,962,000 | -22,141,000 | $16.32 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 2,085,526 | -15,457 | 58,103,000 | -619,000 | $27.86 |
| 03/31/2021 | Revance Therapeutics, Inc. | RVNC | 2,100,983 | -100,525 | 58,722,000 | -3,669,000 | $27.95 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 2,201,508 | -84,534 | 62,391,000 | 4,920,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 2,286,042 | 159,501 | 57,471,000 | 5,541,000 | $25.14 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 2,126,541 | 424,017 | 51,930,000 | 26,733,000 | $24.42 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 1,702,524 | 1,702,524 | 25,197,000 | 25,197,000 | $14.80 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 0 | -34,753 | 0 | -864,000 | |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 34,753 | -1,097,207 | 864,000 | -30,208,000 | $24.86 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 1,131,960 | -351,077 | 31,072,000 | -14,606,000 | $27.45 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 1,483,037 | 625,501 | 45,678,000 | 15,021,000 | $30.80 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 857,536 | 480,008 | 30,657,000 | 20,256,000 | $35.75 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 377,528 | -872 | 10,401,000 | 411,000 | $27.55 |
| 06/30/2017 | Revance Therapeutics, Inc. | RVNC | 378,400 | 378,400 | 9,990,000 | 9,990,000 | $26.40 |
| 09/30/2016 | Revance Therapeutics, Inc. | RVNC | 0 | -78,156 | 0 | -2,326,000 | |
| 12/31/2015 | Revance Therapeutics, Inc. | RVNC | 0 | -78,156 | 0 | -2,326,000 | |
| 09/30/2015 | Revance Therapeutics, Inc. | RVNC | 78,156 | 603 | 2,326,000 | -154,000 | $29.76 |
| 06/30/2015 | Revance Therapeutics, Inc. | RVNC | 77,553 | -31,814 | 2,480,000 | 213,000 | $31.98 |
| 03/31/2015 | Revance Therapeutics, Inc. | RVNC | 109,367 | 242 | 2,267,000 | 418,000 | $20.73 |
| 12/31/2014 | Revance Therapeutics, Inc. | RVNC | 109,125 | -190,069 | 1,849,000 | -3,934,000 | $16.94 |
| 09/30/2014 | Revance Therapeutics, Inc. | RVNC | 299,194 | -821,940 | 5,783,000 | -32,336,000 | $19.33 |
| 06/30/2014 | Revance Therapeutics, Inc. | RVNC | 1,121,134 | 946,162 | 38,119,000 | 32,607,000 | $34.00 |
| 03/31/2014 | Revance Therapeutics, Inc. | RVNC | 174,972 | 174,972 | 5,512,000 | 5,512,000 | $31.50 |
| << Prev Next >> |
|